1-6 of 6
Tobias Wirenfeldt Klausen, M.S.
Close
Save search
Sort by
Journal Articles

High-Grade B-Cell Lymphomas with MYC and BCL2 Translocations Lack Tumor-Associated Macrophages and PD-L1 Expression: A Possible Noninflamed Subgroup

Free
Marie Fredslund Breinholt, MD, Douglas NP de Oliveira, PhD, Tobias Wirenfeldt Klausen, M.S., Lone Schejbel, PhD, Anne Ortved Gang, MDPhD, Mette Ø Pedersen, MDPhD, Mette Vestergaard Elbæk, MD, Erik Clasen-Linde, MD, Signe Ledou Nielsen, MD, Helle Knudsen, MD, Estrid Hogdall, PhD DMSci, Peter H. Norgaard, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134411
Published: 2020
Journal Articles

A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group

Free
Henrik Gregersen, MD PhD, Valdas Peceliunas, MD, Kari Remes, MD PhD, Fredrik H. Schjesvold, MD PhD, Niels Abildgaard, MD, Hareth Nahi, MD PhD, Niels Frost Andersen, MD PhD, Annette Juul Vangsted, MD PhD, Tobias Wirenfeldt Klausen, M.S., Carsten Helleberg, MD, Kristina Carlson, MD, Ulf Christian Frølund, MD, Per Axelsson, MD, Olga Stromberg, MD, Cecilie Hveding Blimark, PhD MD, Olle Linder, MD, Galina Tsykunova, MD, Anders Waage, MD PhD, Markus Hansson, MD PhD, Nina Gulbrandsen
Journal: Blood
Blood (2019) 134 (Supplement_1): 601.
https://doi.org/10.1182/blood-2019-122141
Published: 2019
Journal Articles

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Free
Louise Redder, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD PhD, Henrik Gregersen, MD PhD, Niels Frost Andersen, MD PhD, Robert Schou Pedersen, MD PhD, Torben Plesner, MD DSc, Mikael Frederiksen, MD, Ulf Christian Frølund, MD, Carsten Helleberg, MD, Lene Kongsgaard Nielsen, MD PhD, Morten Salomo, MD PhD, Peter Gimsing, MD DMSc, Henrik Frederiksen, MD PhD Prof, Niels Abildgaard, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1849.
https://doi.org/10.1182/blood-2019-128074
Published: 2019
Journal Articles

Genetic Evidence for Involvement of Human Endogenous Retrovirus Herv-Fc1 in the Pathogenesis of MPNs

Free
Vibe Skov, PhD, Katrine LM Schmidt, Kasper Mønsted Pedersen, MD, Bettina Hansen, Tobias Wirenfeldt Klausen, M.S., Torben A Kruse, Mads Thomassen, PhD, Lasse Kjær, PhD, Christina Ellervik, Associate Professor, MD PhD, Morten Holmstrøm, MD, Bjørn Nexø, Hans Carl Hasselbalch, Professor, dr.MD, Magdalena J Laska
Journal: Blood
Blood (2018) 132 (Supplement 1): 5488.
https://doi.org/10.1182/blood-2018-99-118080
Published: 2018
Journal Articles

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Free
Henrik Gregersen, MD, Niels Abildgaard, MD, Trung Hieu Do, MD, Ida Bruun Kristensen, MD, Ulf Christian Frølund, MD, Niels Frost Andersen, MD, Lene Kongsgaard Nielsen, MD, Christen Lykkegaard Andersen, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3129.
https://doi.org/10.1182/blood.V130.Suppl_1.3129.3129
Published: 2017
Journal Articles

Stratification By MYC Protein Expression Level Improves the Prognostic Impact of MYC Translocation in Patients with Large B-Cell Lymphoma

Free
Mette Ø Pedersen, MD, Anne Ortved Gang, MDPhD, Erik Clasen-Linde, MD, Marie Fredslund Breinholt, MD, Helle Knudsen, MD, Signe Ledou Nielsen, MD, Tim Svenstrup Poulsen, PhD, Tobias Wirenfeldt Klausen, M.S., Estrid Hogdall, PhD, Peter H. Norgaard, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1484.
https://doi.org/10.1182/blood.V130.Suppl_1.1484.1484
Published: 2017